BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Spinnovation Biologics CEO Discusses NMR-based Methods for Bioprocess Optimization at Boston Summit


8/18/2011 10:04:20 AM

18 August 2011: Spinnovation, Nijmegen, The Netherlands: Spinnovation Managing Director, Dr Frederic Girard, will discuss the 'Application of Innovative NMR-based Methods for Bioprocess Optimization and Monitoring of Biological Production' as part of the short course 'Optimizing Media – Achieving Super Soup' being held at this year's Bioprocessing Summit in Boston, MA (22-25 August 2011). The course runs on the morning of Monday 22 August starting at 08.30am.

"This short course is aimed at helping research teams to optimize their cell cultures, setting them up for upstream processing. It is particularly relevant to those who are involved in R&D and the development of biologics, including antibodies and viruses, especially using mammalian cell cultures", said Dr Girard. "My presentation will introduce the basics of NMR technology and methods, and go on to explore how it may be applied to monitor cell cultures and rapidly optimize culture media, and finally examine the benefits it delivers."

Cell culture process development and optimization is critical for the commercially viable production of recombinant protein products and antibodies. Spinnovation Biologics' innovative Spedia-NMR™ profiling methodology provides significant advantage as an analytical and development tool to fully understand and control cell growth conditions as early as possible. Applying Spedia-NMR™ to cell culture samples provides rapid results (usually within five days) to allow optimization of: feed strategies, media formulation and process parameters.

For further information, please visit: www.spinnovation-biologics.com

About Spinnovation Analytical BV

Spinnovation Biologics is a division of Spinnovation Analytical BV (Nijmegen, The Netherlands, www.spinnovation-analytical.com).

Spinnovation is a contract research organization expert in delivering analytical services to the Industry (Pharmaceuticals, Chemicals/Polymers, Food Products). Its expertise and core activity focuses on the use of Nuclear Magnetic Resonance Spectroscopy (NMR) and Mass Spectrometry (MS) to study molecules and materials.

For more information:

For press information, please contact:

Richard Kent, Kapler Communications

Knowledge Centre, Wyboston Lakes, Great North Road,

Wyboston, Bedfordshire, MK44 3BY, UK

Tel: +44 (0)1480 479280; Fax: +44 (0)1480 470343 richard@kapleronline.com

Spinnovation contact:

Dr. Frederic Girard, Spinnovation Analytical BV, Toernooiveld 1, Mercator III, 6525ED Nijmegen, The Netherlands. Tel.: +31(0)24-240-3400, e-mail: info@spinnovation-analytical.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES